Maruti, Honda, Mahindra and others stops manufacturing due to Covid19 outbreak


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Maruti Honda Mahindra and others stops manufacturing due to Covid19 outbreak
All automakers stops production til 31st March

Maruti Suzuki India (MSI), Mahindra & Mahindra and Honda Cars, recentlyannounced suspension of manufacturing activities across plants in the wake of the coronavirus outbreak in the country.

 MSI stopped production at its Gurgaon and Manesar plants with immediate effect, while Honda Cars India Ltd (HCIL) to end manufacturing at its two plants in the country till 31 March.

Meanwhile Mahindra & Mahindra (M&M) announced to suspend production at its manufacturing plants in Maharashtra.

Automaker Fiat also suspends  production in the country till the end of this month.

From other automobile companies,Hero MotoCorp and Honda Motorcycle and Scooter India (HMSI) suspended production across their manufacturing plants.

HMSI said, "The company will shut production and office operations at its facilities in Gurugram and Manesar (Haryana) with immediate effect till further notice."

The company's research and development centre at Rohtak will also remain closed, it added.

The duration of this shutdown will depend upon government policy, MSI said.

The company's two plants in Haryana—Manesar and Gurgaon—churn out 15.5 lakh vehicles per annum.

HCIL said production operations at  manufacturing plants in Greater Noida (Uttar Pradesh) and Tapukara (Rajasthan) will suspended from 23-31 March.

The company said its intention is to restart production on 1 April, however, this will be dependent upon advice from the government, health authorities, and market and supply conditions.

M&M said it has suspended manufacturing operations at its Nagpur plant with immediate effect and will also halt production at Chakan (Pune) and Kandivali (Mumbai) from Monday.

None of the company plants is working on Sunday also, M&M added.

"We are carefully monitoring the rapidly evolving COVID-19 pandemic and will continue to take swift and appropriate action on other plants in Maharashtra and across the nation," the company said.

Meanwhile, all company offices across the country have been ordered to work from home, it added.

Similarly, automaker Fiat Chrysler Automobiles (FCA) together with Fiat India Automobiles Private Limited (FIAPL), FCA's joint venture manufacturing facility in Ranjangaon, said the temporary suspension is in response to the increasing prevalence of positive COVID-19 cases in Maharashtra and particularly in Pune.

"There will be no retrenchment of any plant employees as a result of the plant closure and all will continue to receive their salaries during this closure period", the company said.

MG Motor India said production at its Halol (Gujarat) plant is closed till 25 March.

Market leader Hero MotoCorp said it has suspended production until 31 March.

"With the safety and well-being of its employees as top priority in view of the escalating COVID-19 situation, the company has decided to halt operations at all its global manufacturing facilities—including in India, Colombia and Bangladesh—and the Global Parts Centre (GPC) at Neemrana with immediate effect until 31 March, 2020," Hero MotoCorp said.

Employees at all the other functions and locations, including the Centre of Innovation and Technology (CIT) at Jaipur, will continue to work from home, except for those whose physical presence is necessary to run the day-to-day essential services, it added.

Similarly, Honda Motorcycle and Scooter India (HMSI) said it has suspended operations across its four manufacturing plants in the country with immediate effect.

"The well-being of employees and all stakeholders being the top priority, the company has temporarily announced shutdown of operations across all its four manufacturing plants with immediate effect till further notice," HMSI

Story Input :Firstpost

Tags : #Maruti #Honda #Mahinda #Fiat #Heromotocorp #Hmsi #MGmotor

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026